Metraipolis › archive › dc_efad0083ffb3

Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas — Europe PMC PMID:42558540

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42558540
DOI
10.3389/fimmu.2026.1900443
License (as archived)
solo-consultazione
Archived
2026-10-17T23:24:08.600Z
SHA-256 of the archived text
d00a808b7d689620c1dd71ead4645cc0adc137d4245ae848e03966cd5c78b56e
Stable URL of this page
https://metraipolis.com/documento/dc_efad0083ffb3

How to cite

Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas — Europe PMC PMID:42558540 — Europe PMC (en), https://europepmc.org/article/MED/42558540 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_efad0083ffb3 (Metraipolis archive dc_efad0083ffb3, sha256 d00a808b7d689620c1dd71ead4645cc0adc137d4245ae848e03966cd5c78b56e)
BibTeX
@misc{dcefad0083ffb3,
  title = {Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas — Europe PMC PMID:42558540},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42558540},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_efad0083ffb3; sha256 d00a808b7d689620c1dd71ead4645cc0adc137d4245ae848e03966cd5c78b56e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42558540. Agents can read the archived copy with the MCP tool read_document.